Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Monoclonal antibodies binding to different epitopes of CD20 differentially sensitizes DLBCL to different classes of chemotherapy

ABSTRACT: To investigate the differential gene expression profiles induced by rituximab and ofatumumab, we treated DLBCL cell lines U2932 and TMD8 with these monoclonal antibodies and analyzed their gene expression profiles

ORGANISM(S): Homo sapiens

PROVIDER: GSE228687 | GEO | 2023/04/07

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Monoclonal antibodies binding to different epitopes of CD20 differentially sensitize DLBCL to different classes of chemotherapy.

Project description: Not available

| S-EPMC10436104 | biostudies-literature

Monoclonal antibodies binding to different epitopes of CD20 differentially sensitizes DLBCL to different classes of chemotherapy

Project description:Monoclonal antibodies binding to different epitopes of CD20 differentially sensitizes DLBCL to different classes of chemotherapy

| PRJNA951211 | ENA

The ETS inhibitors YK-4-279 and TK-216 have anti-tumor activity in lymphomas and interfere with SPIB in activated B cell-like type diffuse large B cell lymphoma

Project description:TMD8 and U2932 were treated with YK-4-279 for 4 and 8 hours.

2021-05-01 | GSE114022 | GEO

Anti-CD20 monoclonal antibodies: reviewing a revolution.

Project description: Not available

| S-EPMC6343614 | biostudies-literature

Antigenic analysis of monoclonal antibodies against different epitopes of σB protein of avian reovirus.

Project description: Not available

| S-EPMC3842295 | biostudies-literature

Differential regulation patterns of anti-CD20 mAbs in MCL

Project description:We investigated the differential regulation patterns of type I anti-CD20 monoclonal antibody (mAb) rituximab and type II obinutuzumab on a transcriptional level. Using a panel of MCL cell lines, we determined the effects of obinutuzumab and rituximab as monotherapies as well as in combination on cell viability and proliferation. Obinutuzumab induced a higher reduction in cell proliferation in each mantle cell lymphoma cell line than rituximab did. Results indicate a common pattern of expression changes after binding of anti-CD20 mAbs, but also reveal a significant difference between type I and type II treatment. Combination treatment resulted in a rituximab-like expression pattern. Many deregulated genes were associated with stress signalling, cell death, immune response and other functional clusters. Our analyses identified different and antibody-specific downstream expression patterns of obinutuzumab and rituximab, which may represent the molecular basis of the superior effect of obinutuzumab in comparison to rituximab.

2014-12-31 | GSE54169 | GEO

Generation of anti-human DEC205/CD205 monoclonal antibodies that recognize epitopes conserved in different mammals.

Project description: Not available

| S-EPMC3324822 | biostudies-literature

H1N1 influenza virus epitopes classified by monoclonal antibodies.

Project description: Not available

| S-EPMC6122413 | biostudies-literature

Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies.

Project description: Not available

| S-EPMC4622538 | biostudies-literature

Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia.

Project description: Not available